TY - JOUR
T1 - Correction to
T2 - Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion (Journal of Neurology, (2022), 269, 10, (5382-5394), 10.1007/s00415-022-11193-w)
AU - Filippi, Massimo
AU - Amato, Maria Pia
AU - Centonze, Diego
AU - Gallo, Paolo
AU - Gasperini, Claudio
AU - Inglese, Matilde
AU - Patti, Francesco
AU - Pozzilli, Carlo
AU - Preziosa, Paolo
AU - Trojano, Maria
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/12
Y1 - 2022/12
N2 - The article Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion, written by Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa and Maria Trojano, was originally published Online First without Open Access. After publication in volume 269, issue 10, pages 5382–5394 the author decided to opt for Open Choice and to make the article an Open Access publication.
AB - The article Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion, written by Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa and Maria Trojano, was originally published Online First without Open Access. After publication in volume 269, issue 10, pages 5382–5394 the author decided to opt for Open Choice and to make the article an Open Access publication.
UR - http://www.scopus.com/inward/record.url?scp=85138500293&partnerID=8YFLogxK
U2 - 10.1007/s00415-022-11385-4
DO - 10.1007/s00415-022-11385-4
M3 - Comment/debate
C2 - 36138162
AN - SCOPUS:85138500293
SN - 0340-5354
VL - 269
SP - 6690
EP - 6691
JO - Journal of Neurology
JF - Journal of Neurology
IS - 12
ER -